MDGL

Madrigal Pharmaceuticals News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Madrigal Pharmaceuticals Inc MDGL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.41 -1.1% 126.27 14:02:07
Close Price Low Price High Price Open Price Previous Close
124.71 129.99 128.81 127.68
more quote information »

Recent News

Date Time Source Heading
10/01/202008:00GLOBEMadrigal Pharmaceuticals Announces Three Abstracts Accepted..
9/08/202006:02EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
9/03/202006:50GLOBEMadrigal Pharmaceuticals Exceeds Target Enrollment in Phase..
8/26/202006:50GLOBEMadrigal Pharmaceuticals to Present Secondary Analyses of..
8/19/202019:41EDGARStatement of Changes in Beneficial Ownership (4)
8/19/202019:40EDGARStatement of Changes in Beneficial Ownership (4)
8/10/202019:08EDGARStatement of Changes in Beneficial Ownership (4)
8/06/202008:51EDGARCurrent Report Filing (8-k)
8/06/202006:50GLOBEMadrigal Pharmaceuticals Reports 2020 Second Quarter..
8/06/202006:10EDGARQuarterly Report (10-q)
6/18/202008:39EDGARCurrent Report Filing (8-k)
6/18/202007:54EDGARStatement of Changes in Beneficial Ownership (4)
6/18/202007:49EDGARStatement of Changes in Beneficial Ownership (4)
6/18/202007:44EDGARStatement of Changes in Beneficial Ownership (4)
6/18/202007:42EDGARStatement of Changes in Beneficial Ownership (4)
6/18/202007:40EDGARStatement of Changes in Beneficial Ownership (4)
6/01/202017:20EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
5/29/202016:53EDGARStatement of Changes in Beneficial Ownership (4)
5/29/202016:53EDGARStatement of Changes in Beneficial Ownership (4)
5/07/202008:51EDGARCurrent Report Filing (8-k)
5/07/202006:50GLOBEMadrigal Pharmaceuticals Reports 2020 First Quarter..
5/07/202006:09EDGARQuarterly Report (10-q)
4/29/202017:16EDGARProxy Statement (definitive) (def 14a)
4/14/202006:50GLOBEMadrigal MAESTRO Phase 3 NASH Trials Continue without..
4/02/202019:30EDGARInitial Statement of Beneficial Ownership (3)
3/05/202017:06EDGARStatement of Changes in Beneficial Ownership (4)
3/05/202017:05EDGARStatement of Changes in Beneficial Ownership (4)
3/05/202017:03EDGARStatement of Changes in Beneficial Ownership (4)
3/05/202017:03EDGARStatement of Changes in Beneficial Ownership (4)
2/26/202018:07EDGARStatement of Changes in Beneficial Ownership (4)
2/26/202017:42EDGARStatement of Changes in Beneficial Ownership (4)
2/26/202008:51EDGARCurrent Report Filing (8-k)
2/26/202006:50GLOBEMadrigal Pharmaceuticals Reports 2019 Fourth Quarter and..
2/26/202006:17EDGARAnnual Report (10-k)
2/14/202012:06EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202008:01EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202016:47EDGARStatement of Ownership (sc 13g)
1/28/202009:47EDGARSchedule 13g
12/18/201906:50GLOBEMadrigal Pharmaceuticals Announces First Patient Dosed in..
12/13/201917:14EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
12/13/201914:19EDGARStatement of Changes in Beneficial Ownership (4)
12/13/201914:09EDGARStatement of Changes in Beneficial Ownership (4)
12/13/201913:42EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
12/12/201917:31EDGARCurrent Report Filing (8-k)
12/12/201917:28EDGARProspectus Filed Pursuant to Rule 424(b)(7) (424b7)
12/10/201923:58GLOBEMadrigal Pharmaceuticals Announces Pricing of Secondary..
12/10/201916:37EDGARCurrent Report Filing (8-k)
12/10/201916:01GLOBEMadrigal Pharmaceuticals Announces Secondary Offering of..
11/11/201917:30GLOBEMadrigal Pharmaceuticals Announces Publication in The Lancet..
11/06/201908:32EDGARCurrent Report Filing (8-k)
See more news about this stock »
Your Recent History
NASDAQ
MDGL
Madrigal P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201020 18:17:42